Sage Journals: Discover world-class research

Abstract

Cardiopulmonary bypass (CPB) exposes blood to artificial surfaces, which induces a systemic inflammatory activation.This may contribute to hypotension during CPB. A perceived difference between two membrane oxygenators was noted. Data were collected on 222 consecutive patients; four were excluded from the analysis due to having emergency operations. One hundred and twelve (51%) patients received the Apex oxygenator whilst 106 (49%) received the Quadrox. There was no difference between the two groups in the primary outcome; 90/112 patients (80%) in the Apex group and 77/106 (73%) in the Quadrox group (p=0.18, OR: 0.65; 95% CI: 0.34, 1.22) received meteraminol due to marked hypotension during CPB. There was also no difference in the secondary outcomes, length of stay in ICU (22.8 versus 22.7 hours, (OR 0.79, 95% CI: 0.42, 1.48, p=0.16) and length of stay in hospital (8.5 days versus 8.0 days (OR: 0.83, 95% CI: 0.48, 1.45; p=0.52). The choice of oxygenator between the Apex and Quadrox does not have an effect on hypotension in cardiac surgery.

Keywords

perfusion cardiopulmonary bypass blood pressure oxygenator

Get full access to this article

View all access options for this article.

References

De Silva RJ , Vuylsteke A. Inflammatory response to cardiopulmonary bypass. In: Core topics in cardiac anaesthesia. Macay JH , Arrosmith JE eds. London: Greenwich Medical Media. 2004: 271-274.

Levin MA , Lin HM , Castillo JG , et al. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation 2009; 120: 1664-1671.

Fosse E. , Thelin S. , Svennevig JL , et al. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes: a European multicentre study. Eur J Cardiothorac Surg 1997; 11: 320-327.

Gu YJ , van Oeveren W. , Akkerman C. , et al. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993 ; 55: 917-922.

Deakin CD , Dalrymple-Hay MJR , Jones P. , Monro JL Effects of angiotensin converting enzyme inhibition on systemic vascular resistance and vasoconstrictor requirements during hypothermic cardiopulmonary bypass . Eur J Cardiothorac Surg 1998; 13: 546-550.

Myles PS , Olenikov I. , Bujor MA , Davis BB ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study. Med J Aust. 1993; 158: 675-677.

Pappalardo F. , Valle PD , Crescenzi G. , et al. Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trial. Ann Thorac Surg 2006; 81: 886-891

Ji B. , Wang H. , Miao N. , et al. Clinical evaluation of five commercially available adult oxygenators in terms of pressure drop during normothermic and hypothermic cardiopulmonary bypass. Int J Artif Organs 2010; 33: 310-316.

Guan Y. , Palanzo D. , Kunselman A. , Undar A. Evaluation of membrane oxygenators and reservoirs in terms of capturing gaseous microemboli and pressure drops. Artif Organs 2009; 33: 1037-1043.

10.

Zimmermann AK , Weber N. , Aebert H. , Ziemer G. , Wendel HP Effect of biopassive and bioactive surface-coatings on the hemocompatibility of membrane oxygenators . J Biomed Mater Res B Appl Biomater 2007; 80: 433-439.

11.

Rubin D. Estimating causal effects from large data sets using propensity scores . Ann Intern Med 1997 October 15; 127 (8Part2): 757-763.

12.

Duebener LF , Hagino I. , Schmitt K. , Stamm C. , Zurakowski D. , Jonas RA Effects of hemodilution and phenylephrine on cerebral blood flow and metabolism during cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2004 ; 18: 423-428.

13.

Ascione R. , Talpahewa S. , Rajakaruna C. et al. Splanchnic organ injury during coronary surgery with or without cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg. 2006; 81: 97-103.

14.

Kumle B. , Boldt J. , Suttner SW , Piper SN , Lehmann A. , Blome M. Influence of prolonged cardiopulmonary bypass times on splanchnic perfusion and markers of splanchnic organ function. Ann Thorac Surg 2003; 75: 1558-1564.

15.

Morariu AM , Loef BG , Aarts LP , et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005; 128: 2677-2687.

The effect of oxygenator choice on hypotension during cardiopulmonary bypass

Abstract

Keywords

Get full access to this article

References